140 related articles for article (PubMed ID: 34971496)
1. Poor Adherence to Oral Psychiatric Medication in Adults with Schizophrenia May Be Influenced by Pharmacophobia, High Internal Health Locus of Control and Treatment Duration.
De Las Cuevas C; Baptista T; Motuca M; Villasante-Tezanos GA; Lazary J; Pogany L; De Leon J
Neuropsychopharmacol Hung; 2021 Dec; 23(4):388-404. PubMed ID: 34971496
[TBL] [Abstract][Full Text] [Related]
2. Poor Adherence to Oral Psychiatric Medication in Adults with Bipolar Disorder: The Psychiatrist May have More Influence than in Other Severe Mental Illnesses.
De Las Cuevas C; Villasante-Tezanos GA; Motuca M; Baptista T; Lazary J; Pogany L; De Leon J
Neuropsychopharmacol Hung; 2021 Dec; 23(4):347-362. PubMed ID: 34971399
[TBL] [Abstract][Full Text] [Related]
3. Poor Adherence to Oral Psychiatric Medication in Adults with Depression: Psychological Reactance May Have Specific Effects in Depression.
De Las Cuevas C; Motuca M; Baptista T; Villasante-Tezanos GA; Lazary J; Pogany L; De Leon J
Neuropsychopharmacol Hung; 2021 Dec; 23(4):374-387. PubMed ID: 34971495
[TBL] [Abstract][Full Text] [Related]
4. Adherence to psychiatric medications: Comparing patients with schizophrenia, bipolar disorder and major depression.
Lazary J; Pogany L; De Las Cuevas C; Villasante-Tezanos GA; De Leon J
Neuropsychopharmacol Hung; 2021 Dec; 23(4):363-373. PubMed ID: 34971494
[TBL] [Abstract][Full Text] [Related]
5. Skepticism and pharmacophobia toward medication may negatively impact adherence to psychiatric medications: a comparison among outpatient samples recruited in Spain, Argentina, and Venezuela.
De Las Cuevas C; Motuca M; Baptista T; de Leon J
Patient Prefer Adherence; 2018; 12():301-310. PubMed ID: 29503532
[TBL] [Abstract][Full Text] [Related]
6. Practical Approach to Measuring and Predicting Medication Adherence by Outpatient's SelfReport After More than 10 Years of Research in Psychopharmacology.
De Las Cuevas C; Lazary J; Poganyi L; De Leon J
Neuropsychopharmacol Hung; 2021 Dec; 23(4):336-346. PubMed ID: 34971305
[TBL] [Abstract][Full Text] [Related]
7. Assessment of impact of pharmacophilia and pharmacophobia on medication adherence in patients with psychiatric disorders: A cross-sectional study.
Christudas MJ; Gupta BS; Undela K; Isaac NM; Ram D; Ramesh M
Indian J Pharmacol; 2016; 48(6):701-705. PubMed ID: 28066110
[TBL] [Abstract][Full Text] [Related]
8. Effect of necessity-concern framework and polypharmacy on treatment adherence in psychiatric patients. Comparing an Argentinian with a Spanish sample.
De Las Cuevas C; Villasante-Tezanos AG; Motuca M; de Leon J
Hum Psychopharmacol; 2021 Jul; 36(4):e2776. PubMed ID: 33508164
[TBL] [Abstract][Full Text] [Related]
9. Self-Report for Measuring and Predicting Medication Adherence: Experts' Experience in Predicting Adherence in Stable Psychiatric Outpatients and in Pharmacokinetics.
De Las Cuevas C; de Leon J
Patient Prefer Adherence; 2020; 14():1823-1842. PubMed ID: 33116427
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of the Patient's Health Belief Questionnaire on Psychiatric Treatment.
De Las Cuevas C; de Leon J
Patient Prefer Adherence; 2019; 13():527-536. PubMed ID: 31040653
[TBL] [Abstract][Full Text] [Related]
11. Explaining pharmacophobia and pharmacophilia in psychiatric patients: relationship with treatment adherence.
De Las Cuevas C; Peñate W
Hum Psychopharmacol; 2015 Sep; 30(5):377-83. PubMed ID: 26010762
[TBL] [Abstract][Full Text] [Related]
12. The necessity-concern framework in the assessment of treatment adherence of psychiatric patients and the role of polypharmacy in a Spanish sample.
De Las Cuevas C; Betancort M; de Leon J
Hum Psychopharmacol; 2020 Jan; 35(1):e2721. PubMed ID: 31961461
[TBL] [Abstract][Full Text] [Related]
13. Reviving Research on Medication Attitudes for Improving Pharmacotherapy: Focusing on Adherence.
De Las Cuevas C; de Leon J
Psychother Psychosom; 2017; 86(2):73-79. PubMed ID: 28183085
[TBL] [Abstract][Full Text] [Related]
14. Adherence to antipsychotics and cardiometabolic medication: association with health care utilization and costs.
Hansen RA; Maciejewski M; Yu-Isenberg K; Farley JF
Psychiatr Serv; 2012 Sep; 63(9):920-8. PubMed ID: 22706887
[TBL] [Abstract][Full Text] [Related]
15. Control beliefs, therapeutic relationship, and adherence in schizophrenia outpatients: a cross-sectional study.
Jaeger S; Weißhaupt S; Flammer E; Steinert T
Am J Health Behav; 2014 Nov; 38(6):914-23. PubMed ID: 25207516
[TBL] [Abstract][Full Text] [Related]
16. [Drug compliance and health locus of control in schizophrenia].
Combes C; Feral F
Encephale; 2011 May; 37 Suppl 1():S11-8. PubMed ID: 21600328
[TBL] [Abstract][Full Text] [Related]
17. Attitudes toward antipsychotic medications as a useful feature in exploring medication non-adherence in schizophrenia.
Samalin L; de Chazeron I; Blanc O; Brunel L; Fond G; Llorca PM
Schizophr Res; 2016 Dec; 178(1-3):1-5. PubMed ID: 27637362
[TBL] [Abstract][Full Text] [Related]
18. Do patients with schizophrenia distinguish between attitudes toward antipsychotic medication and pharmacotherapy in general? Validation of the Beliefs About Medication Questionnaire.
Beck EM; Vögelin R; Wirtz M; Cavelti M; Kvrgic S; Vauth R
J Nerv Ment Dis; 2012 Jan; 200(1):33-43. PubMed ID: 22210360
[TBL] [Abstract][Full Text] [Related]
19. Adherence to depot versus oral antipsychotic medication in schizophrenic patients during the long-term therapy.
Stanković Z; Ille T
Vojnosanit Pregl; 2013 Mar; 70(3):267-73. PubMed ID: 23607237
[TBL] [Abstract][Full Text] [Related]
20. Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder.
Greene M; Yan T; Chang E; Hartry A; Touya M; Broder MS
J Med Econ; 2018 Feb; 21(2):127-134. PubMed ID: 28895758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
